Table 1.
Participant Baseline Characteristics
| Total (n = 390) | Perceived bupropion assignment (n = 231) | Perceived placebo assignment (n = 159) | |
|---|---|---|---|
| Demographic variables | |||
| Age in years, mean (SD) | 48.1 (11.2) | 48.6 (11.0) | 47.5 (11.42) |
| Female, n (%) | 246 (63.1%) | 144 (62.3%) | 102 (64.2%) |
| Married/living with partner, n (%) | 113 (29%) | 64 (27.7%) | 49 (30.8%) |
| Monthly income <$1800, n (%) | 241 (61.8%) | 145 (62.8%) | 96 (60.4%) |
| < High school graduate, n (%) | 326 (83.6%) | 190 (82.3%) | 136 (85.5%) |
| Tobacco-related variables | |||
| Cigarettes per day, mean (SD) | 8 (2.5) | 7.9 (2.6) | 8.1 (2.5) |
| Smoke menthol cigarettes, n (%) | 317 (81.3%) | 184 (79.7%) | 133 (83.6%) |
| Smoke within 30 mins of waking, n (%) | 274 (70.3%) | 161 (69.7%) | 113 (71.1%) |
| FTND, mean (SD) | 3.1 (1.7) | 3.1 (1.7) | 3.1 (1.6) |
| Serum cotinine in ng/ml, mean (SD) | 265.9 (155.1) | 255.7 (159.2) | 280.8 (148.1) |
| 24hr quit attempts in last year, mean (SD) | 3.3 (5.9) | 3.7 (6.7) | 2.8 (4.3) |
Note. FTND = Fagerström Test for Nicotine Dependence. No statistically significant differences were found between those who perceived bupropion and those who perceived placebo on any baseline characteristics.